SuperMeat, the Israeli cultivated chicken company, announced a new strategic partnership with Japanese food and biotechnology corporation Ajinomoto.

The purpose of the partnership is to establish a commercially viable supply chain platform for the cultivated meat industry. One of its focus areas is the development of cell growth media, which contains the nutrients needed for animal cell growth.

The cultivated meat market is estimated to grow to $25bn dollars by 2030, up from an expected $2b in 2025. To live up to its promise, the industry must scale rapidly to be compete with conventional meat.

Producing cultivated meat is still too expensive for the average consumer. A significant part of these costs comes from the use of recombinant proteins and growth factors in order to help cells grow and differentiate. The Improvement of this essential aspect of the production of lab meat involves reducing inefficiencies between supply and demand and the introducing food-grade growth factors.

The partnership will combine SuperMeat's technologies and expertise in cultivated meat, with Ajinomoto Co.'s proprietary R&D technologies in the biotechnology field and fermentation. Also, as part of the partnership, Ajinomoto Co. will invest in SuperMeat as one of its corporate venture capital projects.

"In the past year, we have made tremendous strides in product development and scale, setting us up for industrial commercialization," says Ido Savir, CEO of SuperMeat. "We are thrilled to partner with Ajinomoto, a global leader in food and biotechnology, to bring to market scalable, affordable and delicious cultivated meat products in poultry and beyond."

"We look forward to partnering with SuperMeat, whose mission and values align closely with our own, to bring the world more sustainable alternative protein options," said Hiroshi Shiragami, Executive Officer & Senior Vice President, Chief Innovation Officer of Ajinomoto Co. "SuperMeat has an impressive track record of producing high-quality cultivated poultry products that have the potential to impact the global meat supply chain and meet consumer demand."

Unlocking the power of amino acids, the Ajinomoto Group, aims to resolve food and health issues associated with dietary habits and aging, and contribute to greater wellness for people worldwide.

SuperMeat is the first B2B company to address the entire category of poultry meat from fat to muscle. It was also the first cultivated meat company to host a blind tasting event, where three professional chefs tried to distinguish its cultivated chicken from the conventional one.

Its proprietary technology allows it to grow muscle, fat and connective tissue all together in a tissue-like structure. This patent-pending method produces the same nutritional and organoleptic properties of meat products without the use of any scaffolding or carriers.

To learn more, visit supermeat.com